Evidence map›Paper›PMID 38344339›Full record

ArticleMedicine and pharmacy reports2024

Acute onset of Lambert Eaton myasthenic syndrome in prostate adenocarcinoma: a case report.

Nicu Cătălin Drăghici, Elena Olariu, Tudor Dimitrie Lupescu, Fior Dafin Mureşanu

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicine and pharmacy reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 76% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Nicu Cătălin DrăghiciClinical Neurosciences Department, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Elena Olariu"Prof. Dr. Ion Chiricuta" Institute of Oncology, Nuclear Medicine Department, Cluj-Napoca, Romania.
Tudor Dimitrie LupescuClinical Neurosciences Department, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Fior Dafin MureşanuClinical Neurosciences Department, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Research Institute for Analytical Instrumentation · ROInstitute of Oncology Prof. Dr. Ion Chiricuta · ROIuliu Hațieganu University of Medicine and Pharmacy · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lambert Eaton myasthenic syndrome (LEMS) is a rare disorder of the neuromuscular junction. The representative clinical triad consists of proximal muscular weakness, areflexia and autonomic dysfunction. The diagnosis is based on the clinical findings confirmed by voltage-gated calcium channels antibody titer and neurophysiology. We present a 69 year old male with prostate adenocarcinoma and 30 years history of smoking, referred for muscle weakness in the lower limbs and difficulty to climb the stairs.

Indexed as

Lambert Eaton myasthenic syndromeneurophysiologyvoltage-gated calcium channels

Identifiers

PMID38344339
PMCPMC10852129
OpenAlexW4385839499

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.